NVCR Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own NVCR shares is 323, representing 98.3% of the company's common stock.

HRT FINANCIAL LP, in the last quarter, reduced its stake in NVCR by -49.83% restricting it's holding to 88.73 thousand shares of worth nearly $1.39M. STATE STREET CORP also lessened -12.96% of the NVCR shares from its portfolio, reducing its holding to 3.36 million shares of worth $52.56M. CAPITAL WORLD INVESTORS also shunned NVCR shares holding by -29.56% last quarter which brought its holding to 2.31 million shares worth $36.08M.

As per its latest 13F filing, RENAISSANCE TECHNOLOGIES LLC increased its stake in NVCR by 175.78% in the last quarter. The institutional holder raised its holding to 279.58 thousand shares having worth more than $4.37M. SPIDERROCK ADVISORS, LLC also added 100% more shares of NVCR to its portfolio, raising its holding to 88 thousand shares of worth $1.22M. CAPITAL INTERNATIONAL INVESTORS also increased its NVCR shares holding by 0.03% which brought its holding to 8.86 million shares worth $138.55M.

The insider with the most stakes in NVCR is DOYLE WILLIAM F , Executive Chairman at the company. Additionally, NVCR stock is highly held by Chief Operating Officer GROENHUYSEN WILHELMUS CM and Chief Financial Officer Cordova Ashley among others.

Company executives, directors, and other insiders own 9.63% percent of NovoCure Limited's stock. Within the last six months, there have been 6 transaction(s) in which NVCR insiders have sold stock, totaling 4.46K shares. Insiders that have sold shares include PARAVASTHU MUKUND, LEONARD FRANK X, and PURI MICHAL NATH.

There have been 0 transaction(s) during the past 6-months in which NovoCure Limited insiders have bought stock, totalling 0 shares

Around 528.91K NovoCure Limited shares are held by insiders, which represents about 9.63% of NVCR stock.

NVCR Executive Chairman, DOYLE WILLIAM F holds the largest portfolio of the company's shares. NVCR shares owned by DOYLE total nearly 551.18 thousand.

RENAISSANCE TECHNOLOGIES LLC is the largest institutional owner in NVCR which holds 279.58 thousand shares worth $4.37M or 0.26% of the total NVCR shares outstanding followed by HRT FINANCIAL LP with ownership of 88.73 thousand shares representing 0.08% of the NVCR ownership. SPIDERROCK ADVISORS, LLC is the third largest stakeholder with 88 thousand shares or 0.08% of the ownership worth more than $1.22M.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the NVCR is concerned, it is a stock which is optionable.

Number of NVCR shares short is 5.40M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 108.20M shares of NVCR are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, NVCR has 98.52M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for NVCR is 2.97.